Harney S, Wordsworth BP: Genetic epidemiology of rheumatoid arthritis. Tissue Antigens. 2002, 60: 465-473. 10.1034/j.1399-0039.2002.600601.x.
Article
CAS
PubMed
Google Scholar
Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B, Cambon-Thomsen A, Cantagrel A: Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. J Rheumatol. 2002, 29: 15-20.
PubMed
Google Scholar
Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B, Cambon-Thomsen A, Cantagrel A: Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheum. 2002, 46: 1754-1762. 10.1002/art.10336.
Article
CAS
PubMed
Google Scholar
Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG: Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol. 2003, 32: 235-239. 10.1080/03009740310003749.
CAS
PubMed
Google Scholar
Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH: Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun. 2004, 5: 147-149. 10.1038/sj.gene.6364050.
Article
CAS
PubMed
Google Scholar
Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G: Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther. 2004, 6: R199-R207. 10.1186/ar1164.
Article
PubMed Central
PubMed
Google Scholar
Martel-Pelletier J, Welsch DJ, Pelletier JP: Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol. 2001, 15: 805-829. 10.1053/berh.2001.0195.
Article
CAS
PubMed
Google Scholar
Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I: Matrix metalloproteinases in arthritic disease. Arthritis Res. 2002, 4 Suppl 3: S39-S49. 10.1186/ar572.
Article
PubMed
Google Scholar
Mengshol JA, Mix KS, Brinckerhoff CE: Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?. Arthritis Rheum. 2002, 46: 13-20. 10.1002/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S.
Article
CAS
PubMed
Google Scholar
Parks WC, Wilson CL, Lopez-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004, 4: 617-629. 10.1038/nri1418.
Article
CAS
PubMed
Google Scholar
Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998, 58: 5321-5325.
CAS
PubMed
Google Scholar
Price SJ, Greaves DR, Watkins H: Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem. 2001, 276: 7549-7558. 10.1074/jbc.M010242200.
Article
CAS
PubMed
Google Scholar
Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM: Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 1996, 271: 13055-13060. 10.1074/jbc.271.22.13055.
Article
CAS
PubMed
Google Scholar
Jormsjo S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P: Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2001, 21: 1834-1839.
Article
CAS
PubMed
Google Scholar
Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, et al: Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999, 99: 1788-1794.
Article
CAS
PubMed
Google Scholar
Yoon S, Kuivaniemi H, Gatalica Z, Olson JM, Buttice G, Ye S, Norris BA, Malcom GT, Strong JP, Tromp G: MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males. Matrix Biol. 2002, 21: 487-498. 10.1016/S0945-053X(02)00053-7.
Article
CAS
PubMed
Google Scholar
Ladenvall P, Wall U, Jern S, Jern C: Identification of eight novel single-nucleotide polymorphisms at human tissue-type plasminogen activator (t-PA) locus: association with vascular t-PA release in vivo. Thromb Haemost. 2000, 84: 150-155.
CAS
PubMed
Google Scholar
Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM: The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993, 268: 10739-10745.
CAS
PubMed
Google Scholar
North BV, Curtis D, Sham PC: Application of logistic regression to case-control association studies involving two causative loci. Hum Hered. 2005, 59: 79-87. 10.1159/000085222.
Article
PubMed
Google Scholar
Erdfelder E, Faul F, Buchner A: GPower: A general power analysis program. Behav Res Methods Instrum Comput. 1996, 28: 1-11.
Article
Google Scholar
Abecasis GR, Cookson WO: GOLD – graphical overview of linkage disequilibrium. Bioinformatics. 2000, 16: 182-183. 10.1093/bioinformatics/16.2.182.
Article
CAS
PubMed
Google Scholar
Qin ZS, Niu T, Liu JS: Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet. 2002, 71: 1242-1247. 10.1086/344207.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sham PC, Curtis D: Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995, 59: 97-105.
Article
CAS
PubMed
Google Scholar
Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG: Replication validity of genetic association studies. Nat Genet. 2001, 29: 306-309. 10.1038/ng749.
Article
CAS
PubMed
Google Scholar
Busso N, Hamilton JA: Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis. Arthritis Rheum. 2002, 46: 2268-2279. 10.1002/art.10498.
Article
CAS
PubMed
Google Scholar
Sanchez-Pernaute O, Largo R, Calvo E, Alvarez-Soria MA, Egido J, Herrero-Beaumont G: A fibrin based model for rheumatoid synovitis. Ann Rheum Dis. 2003, 62: 1135-1138. 10.1136/ard.2003.011767.
Article
PubMed Central
CAS
PubMed
Google Scholar
So AK, Varisco PA, Kemkes-Matthes B, Herkenne-Morard C, Chobaz-Peclat V, Gerster JC, Busso N: Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost. 2003, 1: 2510-2515. 10.1111/j.1538-7836.2003.00462.x.
Article
CAS
PubMed
Google Scholar
Saxne T, Lecander I, Geborek P: Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis. J Rheumatol. 1993, 20: 91-96.
CAS
PubMed
Google Scholar
Busso N, Peclat V, So A, Sappino AP: Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis. 1997, 56: 550-557.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yang YH, Carmeliet P, Hamilton JA: Tissue-type plasminogen activator deficiency exacerbates arthritis. J Immunol. 2001, 167: 1047-1052.
Article
CAS
PubMed
Google Scholar
Cook AD, Braine EL, Campbell IK, Hamilton JA: Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis. Am J Pathol. 2002, 160: 917-926.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wolf AT, Medcalf RL, Jern C: The t-PA -7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid. Blood. 2005, 105: 1060-1067. 10.1182/blood-2003-12-4383.
Article
CAS
PubMed
Google Scholar
Ladenvall P, Johansson L, Jansson JH, Jern S, Nilsson TK, Tjarnlund A, Jern C, Boman K: Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarction. Thromb Haemost. 2002, 87: 105-109.
CAS
PubMed
Google Scholar
Jannes J, Hamilton-Bruce MA, Pilotto L, Smith BJ, Mullighan CG, Bardy PG, Koblar SA: Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke. 2004, 35: 1090-1094. 10.1161/01.STR.0000124123.76658.6c.
Article
CAS
PubMed
Google Scholar
Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR, Arbeit LA: Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. Clin Immunol Immunopathol. 1996, 78: 161-171. 10.1006/clin.1996.0025.
Article
CAS
PubMed
Google Scholar
Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ: Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. 1996, 39: 1576-1587.
Article
CAS
PubMed
Google Scholar
Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, Kinne RW, Santavirta S, Sorsa T, Lopez-Otin C, Takagi M: Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis. 1999, 58: 691-697.
Article
PubMed Central
CAS
PubMed
Google Scholar
Schurigt U, Stopfel N, Huckel M, Pfirschke C, Wiederanders B, Brauer R: Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis. Arthritis Res Ther. 2005, 7: R174-R188. 10.1186/ar1466.
Article
PubMed Central
CAS
PubMed
Google Scholar
Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R: The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol. 2002, 169: 2643-2647.
Article
CAS
PubMed
Google Scholar
McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM: Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science. 2000, 289: 1202-1206. 10.1126/science.289.5482.1202.
Article
CAS
PubMed
Google Scholar
McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, Overall CM: Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem. 2001, 276: 43503-43508. 10.1074/jbc.M107736200.
Article
CAS
PubMed
Google Scholar
Price SJ, Greaves DR, Watkins H: Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem. 2001, 276: 7549-7558. 10.1074/jbc.M010242200.
Article
CAS
PubMed
Google Scholar
Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D: Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res. 2004, 64: 7622-7628. 10.1158/0008-5472.CAN-04-1521.
Article
CAS
PubMed
Google Scholar
Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L, Lin D: Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res. 2002, 62: 6430-6433.
CAS
PubMed
Google Scholar
Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, Lin D: A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res. 2003, 63: 3987-3990.
CAS
PubMed
Google Scholar
Zhou Y, Yu C, Miao X, Tan W, Liang G, Xiong P, Sun T, Lin D: Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis. 2004, 25: 399-404. 10.1093/carcin/bgh020.
Article
CAS
PubMed
Google Scholar
Lin SC, Lo SS, Liu CJ, Chung MY, Huang JW, Chang KW: Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med. 2004, 33: 405-409. 10.1111/j.1600-0714.2004.00231.x.
Article
CAS
PubMed
Google Scholar
Xu E, Lai M, Lv B, Xing X, Huang Q, Xia X: A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem Biophys Res Commun. 2004, 324: 999-1003. 10.1016/j.bbrc.2004.09.150.
Article
CAS
PubMed
Google Scholar
Holla LI, Fassmann A, Vasku A, Goldbergova M, Beranek M, Znojil V, Vanek J, Vacha J: Genetic variations in the human gelatinase A (matrix metalloproteinase-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis. J Periodontol. 2005, 76: 1056-1060. 10.1902/jop.2005.76.7.1056.
Article
CAS
PubMed
Google Scholar
Mercado FB, Marshall RI, Bartold PM: Inter-relationships between rheumatoid arthritis and periodontal disease. A review. J Clin Periodontol. 2003, 30: 761-772. 10.1034/j.1600-051X.2003.00371.x.
Article
CAS
PubMed
Google Scholar